What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038).
Extended-release buprenorphine
Opioid use disorder
Postpartum
Pregnancy
Journal
Journal of clinical gynecology and obstetrics
ISSN: 1927-1271
Titre abrégé: J Clin Gynecol Obstet
Pays: Canada
ID NLM: 101637359
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
ppublish
Résumé
Weekly and monthly CAM2038 (Brixadi
Identifiants
pubmed: 38435674
doi: 10.14740/jcgo919
pmc: PMC10906993
doi:
Types de publication
Journal Article
Langues
eng
Pagination
110-116Déclaration de conflit d'intérêts
Conflict of Interest Lofwall: research consultant for treatments in development for substance use disorder for Titan Pharmaceuticals, Journey Colab, Berkshire Biomedical and Braeburn. Wilder: none. Young: none. Gray: none. Guille: Visiting Scientist and Research Consultant for Maven Clinic. Leeman: none. Charles: serves as a medical consultant for Gilead Science Inc for hepatitis C treatment in pregnancy and RH Capital. Winhusen: none. Hansen: none. Wachman: none.